Lung Cancer Indicator Detection
NCT02612532 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2603
Last updated 2023-06-18
Summary
The Lung Cancer Indicator Detection (LuCID) study investigates the the diagnostic accuracy of FAIMS for diagnosis of lung cancer by analysis of exhaled Volatile Organic Compounds.
Conditions
Interventions
- DEVICE
-
ReCIVA breath sampler
Device developed for standardised collection of breath samples http://www.owlstonenanotech.com/medical/products/reciva
Sponsors & Collaborators
-
Papworth Hospital NHS Foundation Trust
collaborator OTHER_GOV -
University Hospitals, Leicester
collaborator OTHER -
University College, London
collaborator OTHER -
Universitätsklinikum Leipzig
collaborator OTHER -
University Hospital, Antwerp
collaborator OTHER -
University Hospital, Ghent
collaborator OTHER -
University of Bari
collaborator OTHER -
University of Athens
collaborator OTHER -
Glenfield Hospital
collaborator OTHER -
Peterborough and Stamford Hospitals NHS Foundation Trust
collaborator OTHER -
University Hospitals of North Midlands NHS Trust
collaborator OTHER -
Manchester University NHS Foundation Trust
collaborator OTHER_GOV -
University Hospital Southampton NHS Foundation Trust
collaborator OTHER -
Buckinghamshire Healthcare NHS Trust
collaborator OTHER -
Wirral University Teaching Hospital NHS Trust
collaborator OTHER -
South Tyneside and Sunderland NHS Foundation Trust
collaborator OTHER -
Liverpool University Hospitals NHS Foundation Trust
collaborator OTHER_GOV -
Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
collaborator OTHER -
Barnet and Chase Farm Hospitals NHS Trust
collaborator OTHER -
Liverpool Heart and Chest Hospital NHS Foundation Trust
collaborator OTHER -
Owlstone Ltd
lead INDUSTRY
Principal Investigators
-
Marc P van der Schee, MD, PhD · Owlstone Medical
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-07
- Primary Completion
- 2021-03-31
- Completion
- 2022-12-22
Countries
- Belgium
- Germany
- Italy
- United Kingdom
Study Locations
More Related Trials
-
Understanding Lung Cancer Related Risk Factors and Their Impact
NCT06473870 ·Status: NOT_YET_RECRUITING
-
LC-NMR Study Biomarkers to Detect Lung Cancer
NCT02024113 ·Status: COMPLETED
-
Diagnostic Study for Lung Cancer Detection Test
NCT01700452 ·Status: COMPLETED
-
An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study
NCT01460264 ·Status: ENROLLING_BY_INVITATION
-
Detecting Lung Cancer Based on Exhaled Breath
NCT04419207 ·Status: COMPLETED
-
Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study
NCT06105177 ·Status: RECRUITING
-
Clinical Evaluation of the Lung Cancer AI-based Decision Support Tool in Low-Dose Lung CT
NCT07052773 ·Status: COMPLETED
-
Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection
NCT01383408 ·Status: TERMINATED ·Phase: PHASE2
-
Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project
NCT02613637 ·Status: UNKNOWN
-
An Observational Study of Predictors and Outcomes of Lung Cancer in Never-smokers in the UK
NCT06575439 ·Status: RECRUITING
-
Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker
NCT01700257 ·Status: COMPLETED ·Phase: NA
-
Lung EpiCheck Biomarkers Development Study
NCT06245876 ·Status: RECRUITING
-
'Lung Health Check' Biomarker Study
NCT04957433 ·Status: UNKNOWN
-
Early Detection of Lung Cancer
NCT03181256 ·Status: ACTIVE_NOT_RECRUITING
-
Assay Development for Cancer Biomarkers
NCT02874729 ·Status: UNKNOWN
-
Screening for Lung Cancer in Current or Past Smokers With Chronic Obstructive Pulmonary Disease
NCT00512746 ·Status: COMPLETED ·Phase: NA
-
LUng CAncer focuS - Long-term Monitoring of Bronchogenic Carcinoma Patients (LUCAS)
NCT04228237 ·Status: UNKNOWN
-
Early Lung Cancer Detection Using Computed Tomography
NCT00188734 ·Status: COMPLETED
-
Improving the Early Detection of Lung Cancer by Combining Exosomal Analysis of Hypoxia With Standard of Care Imaging
NCT04629079 ·Status: UNKNOWN
-
Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks
NCT05902559 ·Status: RECRUITING
-
Advancing Lung Cancer Screening: Artificial Intelligence, Multimodal Imaging and Cutting-Edge Technologies for Early Detection and Characterization
NCT06531343 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Early Detection of Lung Tumors by Sniffer Dogs - Evaluation of Sensitivity and Specificity
NCT01141842 ·Status: COMPLETED ·Phase: PHASE1
-
A Micro/Nano Device for Exhaled Breath Analysis
NCT02123030 ·Status: COMPLETED
-
Development and Feasibility Testing of a Lung Cancer Screening Decision Aid
NCT02790866 ·Status: COMPLETED ·Phase: NA
-
Identification of a Plasma Proteomic Signature for Lung Cancer
NCT01752101 ·Status: COMPLETED